Sirolimus Stent (LYNX)


Highlighting Features

  • Lynx is first indigenously developed Drug Eluting Stent in India.
  • The Strut Thickness for Lynx is 65 μm
  • Unique Open and closed Cells Stent Design on L 605 Cobalt Chromium Stent platform with Strut locking mechanism.  This offers excellent radial strength and minimum recoil
  • Improved Stent apposition and Uniform neointimal coverage
  • Inhibits in-stent restenosis (ISR) and late thrombosis with adequate Re- Endothelialization
  • Completely biodegradable, Biocompatible polymer (PLA carrier) – Loading density of 1.2 μg/mm²
  • 3 μm – Uniform coating thickness with precisely programmed release kinetics
  • Designed for utmost safety – Lynx displays one of the lowest entry profile.
  • Hydrophilic Coated Stent Delivery System
  • 90% of Sirolimus is released within 90-120 days
About Product

Brand Name - LYNX

Sirolimus Stent